BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10214347)

  • 1. Molecular methods for the diagnosis of cancer.
    Cairns P; Sidransky D
    Biochim Biophys Acta; 1999 Mar; 1423(2):C11-8. PubMed ID: 10214347
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor markers in hemodialysis patients.
    Arican A; Ozdemir N; Sezer S; Erten Y; Güz G; Turan M; Inanoglu I; Haberal M
    Transplant Proc; 1999 Dec; 31(8):3367-8. PubMed ID: 10616509
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation.
    Reiter MJ; Costello JE; Schwope RB; Lisanti CJ; Osswald MB
    J Comput Assist Tomogr; 2015; 39(6):825-34. PubMed ID: 26248153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of serum tumor markers for the early diagnosis of neoplasm and in health exams for asymptomatic persons].
    Bernabé Caro R; Moreno Nogueira JA
    Rev Clin Esp; 2002 Apr; 202(4):212-4. PubMed ID: 12003731
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring.
    Bidart JM; Thuillier F; Augereau C; Chalas J; Daver A; Jacob N; Labrousse F; Voitot H
    Clin Chem; 1999 Oct; 45(10):1695-707. PubMed ID: 10508114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
    Bekci TT; Senol T; Maden E
    J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interlaboratory surveys of the determination of tumour markers scatter and repeatability of the results.
    Kruse R; Geilenkeuser WJ; Röhle G
    Eur J Clin Chem Clin Biochem; 1993 Mar; 31(3):139-46. PubMed ID: 7683915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor markers in clinical practice: a review focusing on common solid cancers.
    Duffy MJ
    Med Princ Pract; 2013; 22(1):4-11. PubMed ID: 22584792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.
    Kirwan A; Utratna M; O'Dwyer ME; Joshi L; Kilcoyne M
    Biomed Res Int; 2015; 2015():490531. PubMed ID: 26509158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
    Yu M; Wang YH; Abdalla AME; Liu WQ; Mei F; Wang J; Ouyang CX; Li YQ
    J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):722-728. PubMed ID: 25318883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour markers.
    Pandha HS; Waxman J
    QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in the treatment of cancer: opportunities and pitfalls.
    Melichar B
    Clin Chem Lab Med; 2013 Jul; 51(7):1329-33. PubMed ID: 23729626
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-invasive cancer detection: strategies for the identification of novel cancer markers.
    Sorio C; Mauri P; Pederzoli P; Scarpa A
    IUBMB Life; 2006 Apr; 58(4):193-8. PubMed ID: 16754296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor markers in gynecology].
    Alekseeva ML; Fanchenko ND; Novikov EA; Margiani FR
    Akush Ginekol (Mosk); 1995; (5):35-7. PubMed ID: 8579206
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomarkers for the early detection of cancer: an inflammatory concept.
    Roy HK; Khandekar JD
    Arch Intern Med; 2007 Sep; 167(17):1822-4. PubMed ID: 17893302
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of serum tumor markers in the management of patients with malignancy.
    Markman M
    J Cancer Res Clin Oncol; 1993; 119(11):635-6. PubMed ID: 7688748
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A disposable multianalyte electrochemical immunosensor array for automated simultaneous determination of tumor markers.
    Wu J; Yan F; Tang J; Zhai C; Ju H
    Clin Chem; 2007 Aug; 53(8):1495-502. PubMed ID: 17599954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conventional serum tumor markers in liver cancer. Retrospective analysis of 118 patients].
    Arias-Flórez JS; Martínez-Delgado AM; Alarcón-Tarazona ML; Insuasty-Enriquez JS; Díaz-Martínez LA
    Rev Med Chil; 2018 Dec; 146(12):1422-1428. PubMed ID: 30848745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.